BEAM
#1758
Beam Therapeutics Inc. - Common Stock
25.7 0 USD
+0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+4.47%
Variación mensual
+7.08%
Variación en los últimos 6 meses
-6.88%
Cambio anual
-3.38%
Cierres anteriores
24.6 0
Open
24.7 2
Mínimo
24.5 5
Máximo
26.2 3
Financials
- Market Capitalization 2.65 B
- Employee 540
- Founded 2017
- CEO John Evans
- Website www.beamtx.com
- Headquarter Delaware, United States
- FIGI BBG00KXC8646
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-34.22
Relación precio/flujo de caja
19.62
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1718 |  ZLAB Zai Lab Limited - American Depositary Shares | 24.99 USD | +0.73% | +2.25% | +3.05% | -6.37% | 2.81 B USD | ||
| 1721 |  PGEN Precigen, Inc. - Common Stock | 7.81 USD | +2.76% | -8.23% | +13.85% | +140.31% | 2.80 B USD | ||
| 1782 |  NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 21.58 USD | +1.51% | -5.52% | -5.85% | -40.50% | 2.58 B USD | ||
| 1811 |  LQDA Liquidia Corporation - Common Stock | 27.38 USD | -2.28% | -2.46% | -59.01% | +21.15% | 2.45 B USD |